Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lisa.brown
    Junior Member
    • Mar 2012
    • 6

    #1

    Rarefaction

    Is it unacceptable to remove chimeras, shorter than expected reads, and low q-score reads prior to doing a rarefaction analysis? I'm working with 454 16S data and it just makes sense to remove this kind of data from each library prior to alignment and clustering. I've been questioned on my method that told that rarefaction analysis should be calculated on raw data. Thoughts?
    Last edited by lisa.brown; 02-11-2014, 07:29 AM.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Would you have used those reads anyway for downstream analyses? If not, then I would find it difficult to argue against removing them.

    Comment

    • lisa.brown
      Junior Member
      • Mar 2012
      • 6

      #3
      Great! That's my reasoning as well, the removed reads WOULDN'T be used for downstream analysis so why produce rarefaction data that isn't comparable to downstream hierarchy data?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...